Funded Tech Companies
QurAlis
Wondering who provided funding to QurAlis? Amgen Ventures, Sanford Biosciences and Dementia Discovery Fund put venture money into this biopharmaceutical company.
Company Overview
Company Name
QurAlis
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
700 Main St. North
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
QurAlis is specifically focused on discovering and developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/9/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Jonathan Fleming
Chief Executive Officer
Kasper Roet
Chief Scientific Officer
Daniel Elbaum
Founder
Kevin Eggan
Founder
Clifford Woolf
Company Investors
- Amgen Ventures
- Sanford Biosciences
- Dementia Discovery Fund (Jonathan Behr)
- LS Polaris Innovation Fund
- Sanofi Ventures
- Mitsui Global Investment
- INKEF Capital (Roel Bulthuis)
- Droia Ventures
- Mission BioCapital
- MP Healthcare Venture Management
- Mission Bay Capital
- EQT Life Sciences
- ALS Investment Fund
- Dolby Family Ventures
- Mitsui Fudosan
- Polaris Partners (Amy Schulman)
- BioInnovation (Johannes Fruehauf)
- DROIA (Luc Dochez)
- Viva Ventures Biotech
- Alexandria Venture Investments
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs